Patient characteristics
| Non-OB | OB | |
| Subjects | 35 | 14 |
| Age yrs | 39±2.01 | 34.86±3.52 |
| Sex | ||
| Male | 20 | 4 |
| Female | 15 | 10 |
| Transplantation | ||
| Single | 3 | 0 |
| Bilateral | 32 | 14 |
| Indication | ||
| Cystic fibrosis | 23 | 8 |
| Emphysema α1-antitrypsin | 7 | 1 |
| Bronchiectasis | 1 | 1 |
| Fibrosis | 1 | 1 |
| Primary pulmonary hypertension | 0 | 2 |
| Others | 2 | 1 |
| FEV1 % pred | 84.29±3.22 | 38.07±3.53 |
| Months after transplantation | 190.57±143.42 | 88.28±15.54 |
| HLA-A, HLA-B, HLA-DR mismatch | ||
| 0–2 | 0 | 0 |
| 3–4 | 2 | 1 |
| 5–6 | 33 | 13 |
| Cytomegalovirus mismatch (donor +/ recipient −) | 3 | 2 |
| Treatment (if sampled) | ||
| TAC, AZA | 7 | 0 |
| CsA, AZA | 10 | 0 |
| TAC, MMF | 5 | 0 |
| CsA, MMF | 1 | 0 |
| TAC, AZA, AZI | 2 | 4 |
| TAC, MMF, AZI | 10 | 10 |
| Pseudomonas aeruginosa colonisation status | ||
| Pre-transplant colonisation | 24 | 8 |
| Post-transplant re-colonisation | 19 | 8 |
Data are expressed as n or mean±se. OB: obliterative bronchiolitis; FEV1: forced expiratory volume in one second; % pred: % predicted; HLA: human leukocyte antigen; TAC: tacrolimus; AZA: azathioprine; CsA: cyclosporine; MMF: mycophenolate mofetil; AZI: azithromycin.